e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Adverse events of antituberculosis treatment and comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tuberculosis – An important risk factor for lung cancer
R. Rajnoveanu, C. Pop, M. Man, A. Rajnoveanu, A. Muresan, D. Homorodean (Cluj-Napoca, Brasov, Romania)
Source:
Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Session:
Adverse events of antituberculosis treatment and comorbidities
Session type:
Thematic Poster Session
Number:
3150
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Rajnoveanu, C. Pop, M. Man, A. Rajnoveanu, A. Muresan, D. Homorodean (Cluj-Napoca, Brasov, Romania). Tuberculosis – An important risk factor for lung cancer. Eur Respir J 2010; 36: Suppl. 54, 3150
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Multiple kinds of cancer in one person – Lung and breast cancer – And other malignant entities
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010
Lung function in lung cancer – Room for improvement?
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Prognostic factors affecting survival in cases with lung cancer [A lung cancer mapping project in Turkey (LCMPT)]
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013
6-minute-walk in lung cancer – a new predictor for response and the performance status?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Comorbidities – risk factors for relapsed pulmonary TB
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
EGFR
and
hTERT
mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Postoperative complications after pneumonectomy in lung cancer patients – Whether lung function can act as a predictor?
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Survival outcomes in advance non-small cell lung cancer – A developing country scenario
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011
Risk factors for lung cancer worldwide
Source: Eur Respir J 2016; 48: 889-902
Year: 2016
Lung metastases from colorectal cancer – Surgery, early and late postoperative results
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012
Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Risk factors for tuberculosis in patients with early gastric cancer: Is gastrectomy a significant risk factor for tuberculosis?
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Detection of lung cancer on CXR – A comparison of radiologist‘s performance
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010
Risk assessment of venous thromboembolism in lung cancer – Utility of Khorana model
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012
Adrenomedullin – a protective factor in asthma?
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
EGF-receptor mutation in non-small cell lung cancer – Experiences by routine molecular testing in a German lung cancer centre
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Metastasectomy – Benign aggression for patients with metastatic dissemination of colorectal cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Role of
-511C>T/+3953C>T
haplotypes of
IL1B
gene as risk factors of COPD
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept